Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma Jan. 25, 2016 No Comments
UCB's Briviact approved in E.U. as adjunctive treatment for partial-onset seizures Jan. 22, 2016 No Comments
FDA approves Keytruda for first-line treatment of unresectable or metastatic melanoma Dec. 21, 2015 No Comments
FDA approves Otiprio for pediatric patients undergoing tympanostomy tube placement Dec. 14, 2015 No Comments
RSS